Testing infrared scans in ICU patients with ESBL germs

This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.

This trial is testing a new way to use special tests (called integrons) to help doctors decide if they can safely use fewer strong antibiotics for urinary tract infections that are resistant to common treatments. It is for people in the hospital who have a resistant infection and may help reduce side effects and prevent more resistance.

This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.

This trial tests whether reporting antibiotic sensitivity results in under 6 hours helps doctors choose the right β-lactam antibiotic faster for ICU patients with certain bloodstream infections. If you are in the ICU with a Gram-negative infection, your doctors will use a quick test to pick the best treatment.

This study will track how certain hard-to-treat bacteria spread and cause infections in people who are in the intensive care unit (ICU) or have had a stem cell transplant. The goal is to better understand and prevent these infections in vulnerable patients.

This trial studies how well certain new antibiotics work in patients with gram-negative bacterial infections who are receiving extracorporeal life support (like ECMO or dialysis) in the intensive care unit. It uses drug monitoring to make sure the right dose is given.